Literature DB >> 16398654

Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange.

B F Wyllie1, A X Garg, J Macnab, G A Rock, W F Clark.   

Abstract

Despite the favourable response of thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS) to plasma exchange, an early level of mortality persists. Non-response has been associated with a low frequency of exchange. The Rose index of TTP/HUS severity, occasionally used to predict the response of TTP/HUS to plasma exchange, remains unsatisfactory. The purpose of this study was to develop a new index predicting response of TTP/HUS to plasma exchange and to compare it with the Rose index. Retrospective analysis of 171 cases of TTP/HUS from 39 apheresis units across Canada between 1980 and 2001 was conducted. Logistic regression analysis was used to derive a model predicting 6-month mortality from presenting characteristics. The reduced model contained age >40 years, haemoglobin <9.0 g/dl and the presence of a fever at presentation. Gender, platelet count, creatinine and neurological signs were not part of the final model. This model predicted 13.4% of outcome variance. Predictive scores of 0, 2, 4 and 6 correlated with 6-month mortality rates of 12.5%, 14.0%, 31.3% and 61.5% respectively in our source population. This simple model may help identify those patients who would benefit from higher treatment intensity.

Entities:  

Mesh:

Year:  2006        PMID: 16398654     DOI: 10.1111/j.1365-2141.2005.05857.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

1.  ADAMTS13 activity and antigen during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcome.

Authors:  Shangbin Yang; Ming Jin; Shili Lin; Spero Cataland; Haifeng Wu
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

2.  The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome.

Authors:  Di Song; Xiao-Rong Liu; Zhi Chen; Hui-Jie Xiao; Jie Ding; Shu-Zhen Sun; Hong-Yan Liu; Wei-Yi Guo; Su-Xia Wang; Feng Yu; Ming-Hui Zhao
Journal:  Pediatr Nephrol       Date:  2016-12-29       Impact factor: 3.714

Review 3.  Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis.

Authors:  Nay M Tun; Gina M Villani
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

Review 4.  Pathogenesis and prognosis of thrombotic microangiopathy.

Authors:  Masaomi Nangaku; Hiroshi Nishi; Toshiro Fujita
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

Review 5.  Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency.

Authors:  Han-Mou Tsai
Journal:  Hematol Oncol Clin North Am       Date:  2007-08       Impact factor: 3.722

6.  Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.

Authors:  Ygal Benhamou; Cyrielle Assié; Pierre-Yves Boelle; Marc Buffet; Rana Grillberger; Sandrine Malot; Alain Wynckel; Claire Presne; Gabriel Choukroun; Pascale Poullin; François Provôt; Didier Gruson; Mohamed Hamidou; Dominique Bordessoule; Jacques Pourrat; Jean-Paul Mira; Véronique Le Guern; Claire Pouteil-Noble; Cédric Daubin; Philippe Vanhille; Eric Rondeau; Jean-Bernard Palcoux; Christiane Mousson; Cécile Vigneau; Guy Bonmarchand; Bertrand Guidet; Lionel Galicier; Elie Azoulay; Hanspeter Rottensteiner; Agnès Veyradier; Paul Coppo
Journal:  Haematologica       Date:  2012-05-11       Impact factor: 9.941

7.  Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012.

Authors:  Ruchika Goel; Karen E King; Clifford M Takemoto; Paul M Ness; Aaron A R Tobian
Journal:  Transfusion       Date:  2016-04-15       Impact factor: 3.157

8.  Thrombotic Thrombocytopenic Purpura associated with Clopidogrel: a case report and review of the literature.

Authors:  Taleb Azarm; Ayatollah Sohrabi; Hamid Mohajer; Arezou Azarm
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

9.  Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan.

Authors:  Masanori Matsumoto; Charles L Bennett; Ayami Isonishi; Zaina Qureshi; Yuji Hori; Masaki Hayakawa; Yoko Yoshida; Hideo Yagi; Yoshihiro Fujimura
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

10.  Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China.

Authors:  Xiao-Juan Yu; Feng Yu; Di Song; Su-Xia Wang; Yan Song; Gang Liu; Ming-Hui Zhao
Journal:  ScientificWorldJournal       Date:  2014-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.